Cargando…

LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway

BACKGROUND: Many studies showed that long non-coding RNA MALAT1 is served as an oncogene. However, the specific role of MALAT1 in gastric cancer is not fully elucidated. The aim of this study is to elucidate the regulatory effects of MALAT1 on tumor development and cisplatin resistance in gastric ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Qingqiang, Zhang, Tianqi, Li, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078812/ https://www.ncbi.nlm.nih.gov/pubmed/32214850 http://dx.doi.org/10.2147/CMAR.S243796

Ejemplares similares

LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway
por: Dai, Qingqiang, et al.
Publicado: (2020)

lncRNA MALAT1 overexpression promotes proliferation, migration and invasion of gastric cancer by activating the PI3K/AKT pathway
por: Zhu, Kongxi, et al.
Publicado: (2019)

lncRNA MALAT1 Promotes EMT Process and Cisplatin Resistance of Oral Squamous Cell Carcinoma via PI3K/AKT/m-TOR Signal Pathway
por: Wang, Ran, et al.
Publicado: (2020)

LncRNA MALAT1 promotes gastric cancer progression via inhibiting autophagic flux and inducing fibroblast activation
por: Wang, Zhenqiang, et al.
Publicado: (2021)

LncRNA LINC00460 facilitates the proliferation and metastasis of renal cell carcinoma via PI3K/AKT signaling pathway
por: Zhou, Feng-Juan, et al.
Publicado: (2022)

LncRNA LOXL1-AS1 Promotes the Proliferation and Metastasis of Medulloblastoma by Activating the PI3K/AKT Pathway
por: Gao, Ran, et al.
Publicado: (2018)

Effect of Exosomal lncRNA MALAT1/miR-370-3p/STAT3 Positive Feedback Loop on PI3K/Akt Pathway Mediating Cisplatin Resistance in Cervical Cancer Cells
por: Hu, Yi, et al.
Publicado: (2023)

lncRNA EZR-AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway
por: Lu, Di, et al.
Publicado: (2021)

LncRNA TP73-AS1 promoted the progression of lung adenocarcinoma via PI3K/AKT pathway
por: Liu, Chunfeng, et al.
Publicado: (2019)

LncRNA LINC00961 regulates endothelial-mesenchymal transition via the PTEN-PI3K-AKT pathway
por: Hu, Jin-Xing, et al.
Publicado: (2022)

The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis
por: Xia, Hongwei, et al.
Publicado: (2016)

LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway
por: Huang, Yanxia, et al.
Publicado: (2017)

lncRNA KCNQ1OT1 knockdown inhibits colorectal cancer cell proliferation, migration and invasiveness via the PI3K/AKT pathway
por: Duan, Qiaobin, et al.
Publicado: (2020)

A novel lncRNA FPASL regulates fibroblast proliferation via the PI3K/AKT and MAPK signaling pathways in hypertrophic scar: FPASL regulates hypertrophic scar via the AKT and MAPK pathways
por: Ma, Fang, et al.
Publicado: (2022)

METTL3-Mediated m(6)A Modification of lncRNA MALAT1 Facilitates Prostate Cancer Growth by Activation of PI3K/AKT Signaling
por: Mao, Yuanshen, et al.
Publicado: (2022)

LncRNA ENST00113 promotes proliferation, survival, and migration by activating PI3K/Akt/mTOR signaling pathway in atherosclerosis
por: Yao, Xinliang, et al.
Publicado: (2018)

LncRNA TDRG1 Promotes Proliferation, Invasion and Epithelial-Mesenchymal Transformation of Osteosarcoma Through PI3K/AKT Signal Pathway
por: Huang, Yan, et al.
Publicado: (2020)

LncRNA SNHG6 inhibits cell proliferation and metastasis by targeting ETS1 via the PI3K/AKT/mTOR pathway in colorectal cancer
por: Meng, Su, et al.
Publicado: (2019)

LncRNA‐LOC101928316 contributes to gastric cancer progression through regulating PI3K‐Akt‐mTOR signaling pathway
por: Li, Chengyun, et al.
Publicado: (2019)

Correction to: LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway
por: Huang, Yanxia, et al.
Publicado: (2020)

The role of lncRNA MALAT1 in the regulation of hepatocyte proliferation during liver regeneration
por: Li, Cuicui, et al.
Publicado: (2017)

lncRNA MALAT1 participates in metformin inhibiting the proliferation of breast cancer cell
por: Huang, Yongye, et al.
Publicado: (2021)

The Down-Regulation of lncRNA PCAT18 Promotes the Progression of Gastric Cancer via MiR-107/PTEN/PI3K/AKT Signaling Pathway
por: Chen, Ping, et al.
Publicado: (2019)

LncRNA HAND2-AS1 inhibits proliferation and promotes apoptosis of non-small cell lung cancer cells by inactivating PI3K/Akt pathway
por: Gao, Ting, et al.
Publicado: (2020)

lncRNA Gm16410 Mediates PM(2).(5)-Induced Macrophage Activation via PI3K/AKT Pathway
por: Xu, Jingbin, et al.
Publicado: (2021)

Regulatory Networks of LncRNA MALAT-1 in Cancer
por: Fu, Shijian, et al.
Publicado: (2020)

Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
por: Zheng, Miao, et al.
Publicado: (2020)

LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway
por: Liu, Jianmin, et al.
Publicado: (2020)

Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway
por: Li, Chengyun, et al.
Publicado: (2017)

Effect of lncRNA MALAT1 on the Granulosa Cell Proliferation and Pregnancy Outcome in Patients With PCOS
por: Tu, Mixue, et al.
Publicado: (2022)

Upregulation of LncRNA Malat1 Induced Proliferation and Migration of Airway Smooth Muscle Cells via miR-150-eIF4E/Akt Signaling
por: Lin, Li, et al.
Publicado: (2019)

PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways
por: Fu, Xueqiong, et al.
Publicado: (2014)

DKK1 Promotes Epithelial–Mesenchymal Transition and Cisplatin Resistance in Gastric Cancer via Activation of the PI3K/AKT Pathway
por: Li, Jian, et al.
Publicado: (2023)

Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway
por: Yang, Dongyong, et al.
Publicado: (2021)

LncRNA MIR205HG accelerates cell proliferation, migration and invasion in hepatoblastoma through the activation of MAPK signaling pathway and PI3K/AKT signaling pathway
por: Zhang, Wei, et al.
Publicado: (2022)

LncRNA MALAT1 increases the stemness of gastric cancer cells via enhancing SOX2 mRNA stability
por: Xiao, Yiwen, et al.
Publicado: (2019)

lncRNA MALAT1 modulates oxaliplatin resistance of gastric cancer via sponging miR-22-3p
por: Zhang, Zhenming, et al.
Publicado: (2020)

N6-Methyladenosine Modification of LncRNA DUXAP9 Promotes Renal Cancer Cells Proliferation and Motility by Activating the PI3K/AKT Signaling Pathway
por: Tan, Lei, et al.
Publicado: (2021)

lncRNA XLOC013218 promotes cell proliferation and TMZ resistance by targeting the PIK3R2‐mediated PI3K/AKT pathway in glioma
por: Zhou, Jian, et al.
Publicado: (2022)

Silencing of lncRNA MIR31HG promotes nasopharyngeal carcinoma cell proliferation and inhibits apoptosis through suppressing the PI3K/AKT signaling pathway
por: Feng, Bo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tq226kpjhn2co9c47iroao6hc7